NTT
10.6.2019 10:42:10 CEST | Business Wire | Press release
Nippon Telegraph and Telephone Corporation (TOKYO: 9432) (Head office, Chiyoda-ku, Tokyo, Japan; Jun Sawada, President & CEO; hereinafter referred to as “NTT”) has established the “Digital Twin Computing Initiative” as an innovation platform for digital transformation to meet the demands of the coming era for rapid, dynamic transformations of human societies and economies and realize smart societies [1] .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190610005259/en/
Digital Twin Computing aims to transcend the limits of conventional ICT technology by creating diversified cyberspace easily from highly precise digital information reflecting real-world objects such as things, humans and societies, to achieve not only extremely advanced and profound communications, but also achieve large-scale, high-accuracy predictions and simulations of the future. Thus, this initiative also aims to help to solve various social problems around the world, help to create innovative new services and accelerate the creation of smart societies.
The Digital Twin Computing Initiative is part of the Innovative Optical and Wireless Network (IOWN) initiative [2] promoted by NTT.
1. Background to conceptualization
NTT has continued to contribute to the achievement of the modern digital
society through its ubiquitous provision of high-speed, broadband
communications networks and safe, secure information systems. Meanwhile,
digitalization for humans from telephony through to email and social
media, and for things from maps through to digital appliances and
self-driving cars has dramatically advanced. In future, more advanced
digital societies will emerge and more closely unify the real world of
things, humans and societies and their high-precision digital
information counterparts in cyberspace.
These will be the
highly-digitalized next-generation societies in which further expansion
of human knowledge and emotional expression through large-scale,
high-accuracy predictions will be enabled by high-precision digital
information in cyberspace seamlessly linked to the real world.
Furthermore, these societies will be capable of more advanced and more
social communications (e.g. consensus building and decision-making) than
the conventional, familiar communications (e.g. knowledge sharing and
human collaboration).
To clear a path for this future society, NTT
has established the “Digital Twin Computing Initiative” as a new
information and communication initiative to undertake with its future
partners.
2. About Digital Twin Computing (Figure 1)
“Digital twins” have been mainly gaining attention in such fields as
manufacturing. A digital twin is digital information that accurately
represents features (e.g. shapes, conditions and manufacturing
processes) of things such as machine parts [3]
. Digital
information about humans such as images obtained from medical appliances
(e.g. MRI or CT scans) can also be thought of as digital twins.
In
contrast, our proposed “Digital Twin Computing (DTC)” is a computing
paradigm which expands on the above conventional digital twin concept by
enabling humans and things in the real world to be recreated and
interact without restrictions in cyberspace with "digital twin
operations” – computations to exchange, converge, replicate and
synthesize multiple digital twins.
While conventional digital twins
have been mainly used for digital observation or control of physical
objects, DTC aims to expand the scope of such digitalization from things
to humans and enhance communications among humans and things in
cyberspace.
3. The future achievable with Digital Twin Computing
DTC will enable the solutions to a variety of social problems and innovative services described below.
[Simulations at Earth and Outer Space scales] Virtual societies in cyberspace using large-scale digital twins to reproduce global-scale natural conditions (e.g. climate and reserves of resources) or social changes (e.g. populations and GDP) can be constructed to create high-accuracy prediction models for simulating and predicting the near future. These simulations and predictions can be applied to policies for sustainable development goals (SDGs), etc. based on the obtained global-scale resource balance forecasts. Moreover, combining the digital twins of real-world cities (e.g. Tokyo and San Francisco) with outer space digital twins to produce balance simulations of the atmosphere, water, food, and energy will contribute to space development.
[Discovery and resolution of urban issues] Digital twins of cities and their citizens can be used to anonymously collect the experiences, cultures, values, desires and complaints of the citizens. These digital twins can be used to discover latent problems in cities that usually go unnoticed such as dangerous intersections and high accident rate areas, and find solutions optimized for collectives. Also, these digital twins can be used to simulate synergies with other cities and generate “sister cities” with similarities or mutually complementary and unexpected combinations leading to new collaborative relationships for building wealthier cities.
[Prediction and control of diseases] To combat the outbreak of an infectious disease, virtual societies can be created in cyberspace by combining geographical and transport information, etc. with digital twins of people mapping their activity and relationship patterns to accurately make predictions of the spread of the infection and enable real-time active control of the outbreak by controlling the flows of transport and humans, making decisions about class closures in schools or remote learning, and by enabling automatic search and reservation of the most appropriate hospitals.
[Multifaceted personal decision-making] Recording your work skills into a digital twin will allow you to have the digital twin perform daily tasks such as scheduling or making bookings for meeting rooms. In addition, your digital twin could be replicated so that you can alter the digital version of your past self, various situations or pre-supposed knowledge and engage in dialogue between your real-world self and your altered digital twin to attempt to uncover solutions to various problems. Moreover, a number of your digital twins could debate at super high-speed in cyberspace to discover solutions or perspectives that you might not be able to see.
4. The platform driving Digital Twin Computing (Figure 2)
The DTC platform consists of the following four layers; the
“Cyber/physical interaction layer”, a layer to collect the
physical-world data required to generate a digital twin, and to submit
feedback to the physical-world from the application running on the
platform; the “Digital twin layer”, a layer to generate and maintain
digital twins using data received from the Cyber/physical interaction
layer; the “Digital world presentation layer”, a layer to provide the
framework to invoke digital twin operations using digital twins stored
in the Digital twin layer; and the “Application layer”, a layer to
easily create DTC applications using the digital world presentation
layer.
As a crucial aspect of this achievement, the privacy of
humans and the intentions of the owners of things must be fully
respected and information related to them must be handled with all the
necessary care. Thus, this platform must be equipped with security
mechanisms to preserve privacy.
5. Going forward
The success of the Digital Twin Computing Initiative will depend on intimate cooperation across wide-ranging fields of research and technology such as the social sciences, the humanities, natural and applied sciences and interdisciplinary fields. NTT Laboratories aim to achieve the Digital Twin Computing Initiative by collaborating with future professionals and global partners across these wide-ranging fields of research and technology. For details about this Initiative, please refer to the white paper at http://www.ntt.co.jp/svlab/e/DTC/whitepaper.html .
[1] NTT Group Mid-term Management Strategy “Your Value Partner 2025” (in
Japanese)
[2] Innovative Optical and Wireless Network (IOWN)
[3]
Dr. Michael Grieves, Digital Twin: Manufacturing Excellence through
Virtual Factory Replication, 2015
View source version on businesswire.com: https://www.businesswire.com/news/home/20190610005259/en/
Contact:
Inquiries regarding this press release: Nippon Telegraph and Telephone Corporation Research and Development Planning Department iown-pr@hco.ntt.co.jp
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
